1. Home
  2. IKNA vs AMPG Comparison

IKNA vs AMPG Comparison

Compare IKNA & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • AMPG
  • Stock Information
  • Founded
  • IKNA 2016
  • AMPG 2002
  • Country
  • IKNA United States
  • AMPG United States
  • Employees
  • IKNA N/A
  • AMPG N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • AMPG Telecommunications Equipment
  • Sector
  • IKNA Health Care
  • AMPG Telecommunications
  • Exchange
  • IKNA Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • IKNA 52.1M
  • AMPG 46.7M
  • IPO Year
  • IKNA 2021
  • AMPG N/A
  • Fundamental
  • Price
  • IKNA $1.19
  • AMPG $2.15
  • Analyst Decision
  • IKNA Buy
  • AMPG Strong Buy
  • Analyst Count
  • IKNA 2
  • AMPG 1
  • Target Price
  • IKNA $3.00
  • AMPG $5.00
  • AVG Volume (30 Days)
  • IKNA 109.0K
  • AMPG 372.0K
  • Earning Date
  • IKNA 05-08-2025
  • AMPG 05-15-2025
  • Dividend Yield
  • IKNA N/A
  • AMPG N/A
  • EPS Growth
  • IKNA N/A
  • AMPG N/A
  • EPS
  • IKNA N/A
  • AMPG N/A
  • Revenue
  • IKNA N/A
  • AMPG $10,814,140.00
  • Revenue This Year
  • IKNA N/A
  • AMPG $82.37
  • Revenue Next Year
  • IKNA N/A
  • AMPG $76.47
  • P/E Ratio
  • IKNA N/A
  • AMPG N/A
  • Revenue Growth
  • IKNA N/A
  • AMPG N/A
  • 52 Week Low
  • IKNA $0.97
  • AMPG $0.64
  • 52 Week High
  • IKNA $1.94
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 53.94
  • AMPG 54.62
  • Support Level
  • IKNA $1.10
  • AMPG $2.08
  • Resistance Level
  • IKNA $1.20
  • AMPG $2.59
  • Average True Range (ATR)
  • IKNA 0.08
  • AMPG 0.19
  • MACD
  • IKNA 0.01
  • AMPG 0.01
  • Stochastic Oscillator
  • IKNA 74.26
  • AMPG 46.34

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: